cgs 25462 has been researched along with phosphoramidon in 1 studies
Studies (cgs 25462) | Trials (cgs 25462) | Recent Studies (post-2010) (cgs 25462) | Studies (phosphoramidon) | Trials (phosphoramidon) | Recent Studies (post-2010) (phosphoramidon) |
---|---|---|---|---|---|
7 | 0 | 0 | 781 | 12 | 33 |
Protein | Taxonomy | cgs 25462 (IC50) | phosphoramidon (IC50) |
---|---|---|---|
Thermolysin | Bacillus thermoproteolyticus | 0.033 | |
Neprilysin | Rattus norvegicus (Norway rat) | 0.0578 | |
Neprilysin | Oryctolagus cuniculus (rabbit) | 0.0028 | |
Neprilysin | Homo sapiens (human) | 0.0405 | |
Angiotensin-converting enzyme | Homo sapiens (human) | 0.615 | |
Endothelin-converting enzyme 1 | Homo sapiens (human) | 1.0695 | |
P2Y purinoceptor 12 | Homo sapiens (human) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry, C; Blanchard, L; De Lombaert, S; el-Chehabi, L; Erion, MD; Ghai, RD; Sakane, Y; Tan, J; Trapani, AJ | 1 |
1 other study(ies) available for cgs 25462 and phosphoramidon
Article | Year |
---|---|
N-Phosphonomethyl dipeptides and their phosphonate prodrugs, a new generation of neutral endopeptidase (NEP, EC 3.4.24.11) inhibitors.
Topics: Animals; Antihypertensive Agents; Biological Availability; Biphenyl Compounds; Blood Pressure; Half-Life; Neprilysin; Organophosphonates; Phenylalanine; Phosphopeptides; Prodrugs; Rats; Structure-Activity Relationship | 1994 |